Troy Z. Horvat - Concepedia

Author

Troy Z. Horvat

Also Known As

T Horvat, T. Horvat, Troy Z Horvat, Troy Z. Horvat

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Troy Z. Horvat is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, hematology, and microbiology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	69
2	Microbiology	1	1	22
3	Pathology	1	1	22
4	Cancer Therapeutics	1	1	47
5	Clinical Trials	1	1	47

Troy Z. Horvat

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center Troy Z. Horvat, Nelly G. Adel, Thu-Oanh Dang, Journal of Clinical Oncology	2015	1.1K
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Blood Advances	2021	181
Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80+). Claire F. Friedman, Troy Z. Horvat, Janna Minehart, Journal of Clinical Oncology Drug SafetyOncologyAge GroupCancer ManagementMelanoma	2016	47
Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies Aaron D. Goldberg, Troy Z. Horvat, Meier Hsu, Blood	2017	23
The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance Troy Z. Horvat, Joshua J. Pecoraro, Ryan J. Daley, Leukemia Research Pegaspargase IntoleranceErwinia AsparaginasePathogenesisHematologyAcute Lymphoblastic Leukemia	2016	22

Page 1